Shenzhen Bioeasy Biotechnology Co., Ltd.
Shenzhen Stock Exchange 300942.SZ
Shenzhen Bioeasy Biotechnology Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 119.58 M
Shenzhen Bioeasy Biotechnology Co., Ltd. Shareholders' Equity is USD 119.58 M for the year ending December 31, 2023, a -14.48% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Shenzhen Bioeasy Biotechnology Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 139.82 M, a -5.96% change year over year.
-
Shenzhen Bioeasy Biotechnology Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 148.69 M, a 76.77% change year over year.
-
Shenzhen Bioeasy Biotechnology Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 84.12 M, a 10.86% change year over year.
-
Shenzhen Bioeasy Biotechnology Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 75.88 M, a 134.34% change year over year.
Key data
| Date | Shareholders' Equity | Minority Interest | Total Equity | Total Stockholders Equity and Liabilities |
|---|
Market news
Loading...
Don’t Miss A Beat
Shenzhen Stock Exchange: 300942.SZ
| CEO | Mr. Zhaoli Xiao |
| IPO Date | Feb. 9, 2021 |
| Location | China |
| Headquarters | Room 101, Yirui Biological Building |
| Employees | 389 |
| Sector | Consumers Staples |
| Industries | |
Description
Shenzhen Bioeasy Biotechnology Co., Ltd. develops and sells rapid testing instruments and reagents in China. The company offers detection equipment for use in the fields of food, agricultural, dairy, meat, aquatic, honey, drug, and public safety, as well as clinical diagnosis. Shenzhen Bioeasy Biotechnology Co., Ltd. was founded in 2007 and is based in Shenzhen, China.
Key trends
Past 5 years
StockViz Staff
February 2, 2025
Any question? Send us an email